Possibilities of a directed chemotherapy in ovarian cancer
Gazárek, F.; Kudela, M.; Talas, M.; Fingerová, H.
Ceskoslovenska Gynekologie 41(10): 719-721
1976
ISSN/ISBN: 0374-6852 PMID: 1036973 Document Number: 105201
Document emailed within 1 workday
Related Documents
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15Xu, J.; Song, S.; Tang, Z. 1997: Predictive chemotherapy of breast cancer directed by MTT assay in vitro Zhonghua Zhong Liu Za Zhi 19(2): 153-156
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Somers, R.; ten Bokkel Huinink, W.W. 1980: Developments and current possibilities in cancer chemotherapy Nederlands Tijdschrift Voor Geneeskunde 124(41): 1718-1722
Ozols, R.F.; Young, R.C. 1991: Chemotherapy of ovarian cancer Seminars in Oncology 18(3): 222-232
Camci, C.; Balat, O. 2002: Neoadjuvant chemotherapy in ovarian cancer European Journal of Gynaecological Oncology 23(5): 437-441
Wang, J.; Li, A.J.; Karlan, B.Y. 2002: Chemotherapy in epithelial ovarian cancer Current Women's Health Reports 2(1): 20-26
Ochiai, K. 1994: Tumors. a. Chemotherapy of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 46(8): 821-831
Onda, T. 2012: Neoadjuvant chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(6): 882-886
Anselmo-Murphy, A.M. 2009: Challenges of IP chemotherapy for ovarian cancer Oncology 23(11 Suppl Nurse Ed): 21-22
Nishimura, H.; Imamura, K.; Chang, C. 1996: Chemotherapy for recurrent ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1124-1128
Paulus, A.; Gennigens, C.; Fillet, G.; Loly, C.; Sautois, B. 2007: Chemotherapy of ovarian cancer: state of the art Revue Medicale de Liege 62(9): 539-547
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
1996: Chemotherapy of ovarian and breast cancer with Taxol Deutsche Medizinische Wochenschrift 121(50 Suppl): 1-12
Lehoczky, O.ó 2005: Neoadjuvant chemotherapy in the treatment of ovarian cancer Orvosi Hetilap 146(38): 1951-1955
De Gramont, A.; Marpeau, L.; Demuynck, B.; Louvet, C.; Varette, C.; Gonzalez-Canali, G.; Pigné, A.; Herbulot, P.; Lagadec, B.; Cady, J. 1991: Results of intraperitoneal chemotherapy of ovarian cancer Journal de Gynecologie Obstetrique et Biologie de la Reproduction 20(3): 387-392
Ozols, R.F. 1999: Chemotherapy for ovarian cancer: beyond paclitaxel plus carboplatin Cancer Journal from Scientific American 5(6): 336-338
Sherman, A.I.; Rosenberg, R.; Fink, D. 1992: Use of intraperitoneal chemotherapy for treatment of ovarian cancer European Journal of Gynaecological Oncology 13(4): 295-305
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237